Skip to main content

Publisher: Wiley-Blackwell

Volume 15, Number 5, September 2009

Paediatric haemophilia with inhibitors: existing management options, treatment gaps and unmet needs
pp. 983-989(7)
Authors: SANTAGOSTINO, E.; MORFINI, M.; AUERSWALD, G. K.-H.; BENSON, G. M.; ŠALEK, S. Z.; LAMBERT, T.; SALAJ, P.; JIMENEZ-YUSTE, V.; LJUNG, R. C. R.

Favourites:
ADD

Pregnancy and rare bleeding disorders
pp. 990-1005(16)
Authors: KADIR, R.; CHI, C.; BOLTON-MAGGS, P.

Favourites:
ADD
Favourites:
ADD

Age-dependent increase of FVIII:C in mild haemophilia A
pp. 1022-1026(5)
Authors: MIESBACH, W.; ALESCI, S.; KREKELER, S.; SEIFRIED, E.

Favourites:
ADD

Inhibitors in factor IX deficiency a report of the ISTH-SSC international FIX inhibitor registry (1997–2006)
pp. 1027-1031(5)
Authors: CHITLUR, M.; WARRIER, I.; RAJPURKAR, M.; LUSHER, J. M.

Favourites:
ADD

Assessment of haemophilia treatment practice pattern in Japan
pp. 1032-1038(7)
Authors: ONO, O.; SUZUKI, Y.; YOSIKAWA, K.; WADA, I.; DOI, Y.; TAKANO, M.; WADA, Y.; FUKUSHIMA, K.

Favourites:
ADD

Psychometric evaluation of a patient-reported symptom assessment tool for adults with haemophilia (the HAEMO-SYM)
pp. 1039-1047(9)
Authors: RENTZ, A.; FLOOD, E.; BUTLER, R.; CHRISTIE, B.; GIANGRANDE, P.; McCUSKER, P.; WASSERMAN, J.; GORINA, E.

Favourites:
ADD

The mutation spectrum associated with type 3 von Willebrand disease in a cohort of patients from the North West of England
pp. 1048-1057(10)
Authors: SUTHERLAND, M. S.; KEENEY, S.; BOLTON-MAGGS, P. H. B.; HAY, C. R. M.; WILL, A.; CUMMING, A. M.

Favourites:
ADD

Molecular characterization of Iranian patients with type 3 von Willebrand disease
pp. 1058-1064(7)
Authors: SHAHBAZI, S.; MAHDIAN, R.; ALA, F. A.; LAVERGNE, J.-M.; DENIS, C. V.; CHRISTOPHE, O. D.

Favourites:
ADD

Lower doses of rFVIIa therapy are safe and effective for surgical interventions in patients with severe FXI deficiency and inhibitors
pp. 1065-1073(9)
Authors: KENET, G.; LUBETSKY, A.; LUBOSHITZ, J.; RAVID, B.; TAMARIN, I.; VARON, D.; MARTINOWITZ, U.

Favourites:
ADD

Risk factors for inhibitor formation in haemophilia: a prevalent case–control study
pp. 1074-1082(9)
Authors: RAGNI, M. V.; OJEIFO, O.; FENG, J.; YAN, J.; HILL, K. A.; SOMMER, S. S.; TRUCCO, M. N.; BRAMBILLA, D. J.

Favourites:
ADD

Comparison of radiography, CT and MR imaging in detection of arthropathies in patients with haemophilia
pp. 1090-1096(7)
Authors: YU, W.; LIN, Q.; GUERMAZI, A.; YU, X.; SHANG, W.; ZHU, H.; MENG, W.; XU, R.; ZHAO, Y.

Favourites:
ADD

Clinical outcome of interferon and ribavirin combination treatment in hepatitis C virus infected patients with congenital bleeding disorders in Iran
pp. 1097-1103(7)
Authors: RAHMANI, M.; TOOSI, M. N.; GHANNADI, K.; LARI, G. R.; JAZEBI, M.; RASOULZADEGAN, M.; ALA, F.

Favourites:
ADD
Favourites:
ADD

Thrombin generation and bleeding in haemophilia A
pp. 1118-1125(8)
Authors: BRUMMEL-ZIEDINS, K. E.; WHELIHAN, M. F.; GISSEL, M.; MANN, K. G.; RIVARD, G. E.

Favourites:
ADD

Thromboelastography reflects global hemostatic variation among severe haemophilia A dogs at rest and following acute exercise
pp. 1126-1134(9)
Authors: OTHMAN, M.; POWELL, S.; CHIRINIAN, Y.; HEGADORN, C.; HOPMAN, W.; LILLICRAP, D.

Favourites:
ADD
Favourites:
ADD

Factor 5 mutation profile in German patients with homozygous and heterozygous factor V deficiency
pp. 1143-1153(11)
Authors: DELEV, D.; PAVLOVA, A.; HEINZ, S.; SEIFRIED, E.; OLDENBURG, J.

Favourites:
ADD

von Willebrand disease in the 21st century: current approaches and new challenges
pp. 1154-1158(5)
Authors: MANNUCCI, P. M.; FEDERICI, A. B.; JAMES, A. H.; KESSLER, C. M.

Favourites:
ADD

Haemophilia gene therapy: the patients’ perspective
pp. 1159-1161(3)
Authors: COSTEA, I.; ISASI, R.; KNOPPERS, B. M.; LILLICRAP, D.

Favourites:
ADD

Management of coronary artery disease in a severe haemophilia patient with high titre inhibitor and anaphylaxis
pp. 1161-1163(3)
Authors: RIVOLTA, G. F.; DI PERNA, C.; FRANCHINI, M.; IPPOLITO, L.; MAURIZIO, A. R.; ROCCI, A.; TAGLIAFERRI, A.

Favourites:
ADD

Misleading one-stage coagulation factor assay during rFVIIa treatment in lupus patient
pp. 1164-1166(3)
Authors: HERBERS, A.H.E.; VERBRUGGEN, B.; VAN DE VEERDONK, F.; VAN KRAAIJ, M.; BLIJLEVENS, N.M.A.; NOVAKOVA, I.R.O.

Favourites:
ADD

Postpartum acquired haemophilia: a single centre experience with rituximab
pp. 1166-1168(3)
Authors: DEDEKEN, L.; ST-LOUIS, J.; DEMERS, C.; MEILLEUR, C.; RIVARD, G. E.

Favourites:
ADD

Refinement of a sonographic protocol for assessment of haemophilic arthropathy
pp. 1168-1171(4)
Authors: KESHAVA, S.; GIBIKOTE, S.; MOHANTA, A.; DORIA, A. S.

Favourites:
ADD
Favourites:
ADD

Lymphoid hyperplasia with ulnar nerve compression in a severe haemophilia B patient–case report
pp. 1173-1176(4)
Authors: LU, S. C.; LI, T. Y.; LAI, M. H.; WU, Y. T.; CHANG, S. T.; HOU, W. C.

Favourites:
ADD

Small insertion (c.869insC) within F13A gene is dominant in Tunisian patients with inherited FXIII deficiency due to ancient founder effect
pp. 1176-1179(4)
Authors: EL MAHMOUDI, H.; AMOR, M. B.; GOUIDER, E.; HORCHANI, R.; HAFSIA, R.; FADHLAOUI, K.; MEDDEB, B.; HAFSIA, A.; AMMAR EL GAAIED, A. B.

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more